What does Pharmacie du Peterbos do?

Pharmacie du Peterbos is a pharmacy in Anderlecht. Private Limited, started on 17 December 2010, 1 establishment.

What is the address of Pharmacie du Peterbos?

The registered office of Pharmacie du Peterbos is located at Peterbospark 9 box 42, 1070 Anderlecht.

Is Pharmacie du Peterbos still active?

Yes. According to the CBE (30 September 2026) Pharmacie du Peterbos is active, legal situation “Normale toestand”, started on 17 December 2010.

Is Pharmacie du Peterbos registered on Peppol?

Yes, Pharmacie du Peterbos is registered on the Peppol network with ID 0208:0832002850.

What is the enterprise number of Pharmacie du Peterbos?

The enterprise number of Pharmacie du Peterbos is BE0832002850.

When was Pharmacie du Peterbos founded?

Pharmacie du Peterbos was founded on 17 December 2010.

Who are the directors of Pharmacie du Peterbos?

According to the 2025 annual accounts, the directors of Pharmacie du Peterbos are: SOLINA DUSABEMARIYA.

Is Pharmacie du Peterbos a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 17 December 2010; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Pharmacie du Peterbos make in 2025?

Pharmacie du Peterbos recorded a loss after taxes of € 26,083 in financial year 2025.

What is the revenue of Pharmacie du Peterbos?

As a small company, Pharmacie du Peterbos is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 104,640.

Pharmacie du Peterbos (Private Limited) - Anderlecht

Dossier Pharmacie du Peterbos, printed on 30 September 2026 from databakkes.be/en/0832002850/pharmacie-du-peterbos. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Negative equity NBB

More debt than assets in 2 of the last 4 fiscal years.
Tight liquidity NBB

Cash and receivables cover 37 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Pharmacie du Peterbos from Anderlecht, company number BE0832002850, closed financial year 2025 with a result of € -26,083 after tax. For that financial year Pharmacie du Peterbos recorded a gross margin of € 104,640 and equity of € -10,432. Compared with financial year 2024, the result moved from € 6,945 to € -26,083. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 21, 2026.

What it is worth Caution

€ -10,432

▼ € 26,083 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -26,083

▼ still € 6,945 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 5,597

▼ 65% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -16,632.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Wage cost

€ 116,533

▲ 27% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 53,841

▼ 38% vs 2024

€ 16,732 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 109,996

▲ 10% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 28,013

▲ 18% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 181,285 Gross margin 2022: € 181,285 First fiscal year in the series	€ 103,547 Gross margin 2023: € 103,547 ▼ 43% vs 2022 (€ 181,285) Unfavourable step	€ 109,264 Gross margin 2024: € 109,264 ▲ 6% vs 2023 (€ 103,547) Favourable step	€ 104,640 Gross margin 2025: € 104,640 ▼ 4% vs 2024 (€ 109,264) Unfavourable step	▼ 4%
Profit after taxes	€ 89,165 Profit after taxes 2022: € 89,165 First fiscal year in the series	€ 27,033 Profit after taxes 2023: € 27,033 ▼ 70% vs 2022 (€ 89,165) Unfavourable step	€ 6,945 Profit after taxes 2024: € 6,945 ▼ 74% vs 2023 (€ 27,033) Unfavourable step	€ -26,083 Profit after taxes 2025: € -26,083 ▼ € 33,028 vs 2024 (€ 6,945) Unfavourable step	▼ € 33,028
Equity	€ -18,328 Equity 2022: € -18,328 First fiscal year in the series	€ 8,706 Equity 2023: € 8,706 ▲ € 27,033 vs 2022 (€ -18,328) Favourable step	€ 15,651 Equity 2024: € 15,651 ▲ 80% vs 2023 (€ 8,706) Favourable step	€ -10,432 Equity 2025: € -10,432 ▼ € 26,083 vs 2024 (€ 15,651) Unfavourable step	▼ € 26,083
Total debts	€ 136,905 Total debts 2022: € 136,905 First fiscal year in the series	€ 114,453 Total debts 2023: € 114,453 ▼ 16% vs 2022 (€ 136,905) Favourable step	€ 211,512 Total debts 2024: € 211,512 ▲ 85% vs 2023 (€ 114,453) Unfavourable step	€ 192,047 Total debts 2025: € 192,047 ▼ 9% vs 2024 (€ 211,512) Favourable step	▼ 9%
Cash	€ 9,519 Cash 2022: € 9,519 First fiscal year in the series	€ 12,901 Cash 2023: € 12,901 ▲ 36% vs 2022 (€ 9,519) Favourable step	€ 15,916 Cash 2024: € 15,916 ▲ 23% vs 2023 (€ 12,901) Favourable step	€ 5,597 Cash 2025: € 5,597 ▼ 65% vs 2024 (€ 15,916) Unfavourable step	▼ 65%
Retained profit	€ -24,528 Retained profit 2022: € -24,528 First fiscal year in the series	€ 2,506 Retained profit 2023: € 2,506 ▲ € 27,033 vs 2022 (€ -24,528) Favourable step	€ 9,451 Retained profit 2024: € 9,451 ▲ 277% vs 2023 (€ 2,506) Favourable step	€ -16,632 Retained profit 2025: € -16,632 ▼ € 26,083 vs 2024 (€ 9,451) Unfavourable step	▼ € 26,083
Bank debt	€ 17,220 Bank debt 2022: € 17,220 First fiscal year in the series	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 17,220) Favourable step	€ 87,340 Bank debt 2024: € 87,340 Unchanged (€ 0) Unfavourable step	€ 53,841 Bank debt 2025: € 53,841 ▼ 38% vs 2024 (€ 87,340) Favourable step	▼ 38%
Balance sheet total	€ 118,578 Balance sheet total 2022: € 118,578 First fiscal year in the series	€ 123,159 Balance sheet total 2023: € 123,159 ▲ 4% vs 2022 (€ 118,578) Unchanged	€ 227,162 Balance sheet total 2024: € 227,162 ▲ 84% vs 2023 (€ 123,159) Unchanged	€ 181,615 Balance sheet total 2025: € 181,615 ▼ 20% vs 2024 (€ 227,162) Unchanged	▼ 20%

Key figures of Pharmacie du Peterbos, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Pharmacie du Peterbos?

What happened at Pharmacie du Peterbos in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 21, 2026 New annual accounts for financial year 2025: loss of € 26,083 (▼ € 33,028 vs 2024). filed late Source: NBB ↗
Dec 17, 2010 New establishment in Anderlecht. KBO
Dec 17, 2010 Start of the company according to the CBE. KBO

In short

From € 89,165 profit in 2022 to € 26,083 loss in 2025.

Paid € 15,520 in corporate taxes since 2022.

Best year ever: 2022, with € 89,165 profit.

Original PDFs at the National Bank ↗

A new publication or filing at Pharmacie du Peterbos? We notify you, reason included.

Follow Pharmacie du Peterbos

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

SOLINA DUSABEMARIYA

Pharmacie du Peterbos

Behind Pharmacie du Peterbos is SOLINA DUSABEMARIYA.

See the full network in the app

Directors

According to the 2025 annual accounts

SOLINA DUSABEMARIYA

Administrator-manager

Establishments

Establishment units

Physical locations of this company

Registered office

Peterbospark 9 box 42

1070 Anderlecht

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0832.002.850
VAT number: BE 0832.002.850
Registered office: Peterbospark 9 bus 42, 1070 Anderlecht
Names & denominations: Pharmacie du Peterbos
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 17 December 2010
Peppol: Active · Active since 21 Nov 2025
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗